Sa1469 - The Early Molecular Events for Multi-Focal Hepatocellular Carcinoma
Manling Huang,Ning Zhang,Lixia Xu,Sui Peng
DOI: https://doi.org/10.1016/s0016-5085(18)33736-3
IF: 29.4
2018-01-01
Gastroenterology
Abstract:Background:In China, primary hepatocellular carcinoma (HCC) is one of the most important malignant tumors, with characters of insidious onset, rapid growth and poor prognosis.Chemotherapy is one of the main treatments for HCC.However, drug resistance seriously limits the effect.Therefore, it is critical to make clear the mechanisms of drug resistance in HCC and to explore new targets to improve the sensitivity of HCC chemotherapy.Protocadherin 20 has been reported as a tumor suppressor gene in several cancers.Nevertheless, there is no study with large scale samples evaluating the relationship between PCDH20 protein expression and prognosis of HCC patients, and little is known about its role in mediating HCC chemotherapy.Methods: Firstly, the stably transfected cell lines expressing PCDH20 was constructed in SMMC7721.Cell viability and IC 50 were detected by CCK8.Apoptosis, cell cycles, the population of cells with CD44 + CD133 + phenotype and the drug efflux function were analyzed by flow cytometry.Meanwhile, the expression of PARP, Caspase-8, T-SMAD3, P-SMAD3, MDR1, NANOG, CD44 and CD133 were detected by Real-time PCR or Western blot.Subsequently, resistant strain SMMC7721/R was constructed, and then transfected with PCDH20 or empty vector plasmid by lipofectamine 3000.Related genes and biological characteristics were detected in resistant strains in the same way above.Results: Ectopic expression of PCDH20 resulted in a promotion in the apoptosis induced by Oxaliplatin, and a reduction of the IC 50 value of Oxaliplatin and Paclitaxel, the expression of P-SMAD3,